Literature DB >> 7698799

Promotion and inhibition of activation-induced apoptosis in T-cell hybridomas by oncogenes and related signals.

D R Green1, A Mahboubi, W Nishioka, S Oja, F Echeverri, Y Shi, J Glynn, Y Yang, J Ashwell, R Bissonnette.   

Abstract

The Two Signal: Death/Survival Model suggests that cellular proliferation and physiological cell death should be intimately associated such that, in the absence of external influences, a normal cell departing from rest will have an equal probability of undergoing either process. The c-Myc protooncogene product has been implicated in cell cycle progression and in the control of gene expression, and more recently c-Myc has also been seen to promote apoptotic cell death. As predicted from the model, c-Myc-induced apoptosis is inhibited by growth factors or other anti-apoptotic signals including those provided by some oncogenes. Here, we discuss experiments that test the Two Signal: Death/Survival Model in the phenomenon of activation-induced apoptosis in T-cell hybridomas. Ligation of the antigen receptor on these cells leads to activation, resulting in cytokine production and apoptosis. Inhibition of c-Myc expression by addition of antisense oligodeoxynucleotides or transforming growth factor beta inhibits this form of apoptosis. Because c-Myc is known to bind to several cellular proteins, including Max, we further examined the effects of expression of a dominant negative Max on activation-induced apoptosis. We found that this Max mutant, which interferes with the function of the Myc/Max heterodimer, inhibits the induction of apoptosis by antigen receptor ligation. Thus, both Myc and Max play roles in activation-induced apoptosis, presumably via control of gene expression. Further, as predicted, signals generated from growth factor receptors or the v-Abl oncogene interfere with activation-induced apoptosis. In contrast, the anti-apoptotic effects of Bcl-2 are not active in this form of apoptosis. Finally, a role for Fas/Fas-ligand interactions in activation-induced apoptosis is considered.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7698799     DOI: 10.1111/j.1600-065x.1994.tb00895.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  12 in total

1.  A novel immunosuppressant, FTY720, increases the efficiency of a superantigen-induced peripheral T-cell deletion whilst inhibiting negative selection in the thymus.

Authors:  C Shimizu; X Li; M Kimura; K Hashimoto; K Sugaya; M Kubo; S Suzuki; T Nakayama
Journal:  Immunology       Date:  1998-08       Impact factor: 7.397

2.  CD4 regulates the efficiency of an endogenous superantigen-induced clonal deletion of TCRV beta 11+ cells in the periphery.

Authors:  S Kubo; A Hasegawa; K Hashimoto; C Shimizu; M Kubo; T Tada; T Nakayama
Journal:  Immunology       Date:  1997-12       Impact factor: 7.397

3.  Inhibition of the Raf-1 kinase by cyclic AMP agonists causes apoptosis of v-abl-transformed cells.

Authors:  E M Weissinger; G Eissner; C Grammer; S Fackler; B Haefner; L S Yoon; K S Lu; A Bazarov; J M Sedivy; H Mischak; W Kolch
Journal:  Mol Cell Biol       Date:  1997-06       Impact factor: 4.272

4.  Versatility of using major histocompatibility complex class II dextramers for derivation and characterization of antigen-specific, autoreactive T cell hybridomas.

Authors:  Bharathi Krishnan; Chandirasegaran Massilamany; Rakesh H Basavalingappa; Rajkumar A Rajasekaran; Charles Kuszynski; Barbara Switzer; Daniel A Peterson; Jay Reddy
Journal:  J Immunol Methods       Date:  2015-08-09       Impact factor: 2.303

5.  Mitochondrial release of caspase-2 and -9 during the apoptotic process.

Authors:  S A Susin; H K Lorenzo; N Zamzami; I Marzo; C Brenner; N Larochette; M C Prévost; P M Alzari; G Kroemer
Journal:  J Exp Med       Date:  1999-01-18       Impact factor: 14.307

6.  Bcl-2 inhibits the mitochondrial release of an apoptogenic protease.

Authors:  S A Susin; N Zamzami; M Castedo; T Hirsch; P Marchetti; A Macho; E Daugas; M Geuskens; G Kroemer
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

7.  Transforming growth factor beta1 inhibits Fas ligand expression and subsequent activation-induced cell death in T cells via downregulation of c-Myc.

Authors:  L Genestier; S Kasibhatla; T Brunner; D R Green
Journal:  J Exp Med       Date:  1999-01-18       Impact factor: 14.307

8.  Pramanicin analog induces apoptosis in human colon cancer cells: critical roles for Bcl-2, Bim, and p38 MAPK signaling.

Authors:  Cagri Bodur; Ozgur Kutuk; Gizem Karsli-Uzunbas; Tayirjan T Isimjan; Paul Harrison; Huveyda Basaga
Journal:  PLoS One       Date:  2013-02-18       Impact factor: 3.240

9.  Loss of TAL-1 protein activity induces premature apoptosis of Jurkat leukemic T cells upon medium depletion.

Authors:  K Leroy-Viard; M A Vinit; N Lecointe; H Jouault; U Hibner; P H Roméo; D Mathieu-Mahul
Journal:  EMBO J       Date:  1995-05-15       Impact factor: 11.598

10.  Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death.

Authors:  N Zamzami; P Marchetti; M Castedo; D Decaudin; A Macho; T Hirsch; S A Susin; P X Petit; B Mignotte; G Kroemer
Journal:  J Exp Med       Date:  1995-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.